Your browser is no longer supported. Please, upgrade your browser.
NVUS Novus Therapeutics, Inc. daily Stock Chart
Novus Therapeutics, Inc.
Index- P/E- EPS (ttm)-1.17 Insider Own4.59% Shs Outstand16.98M Perf Week133.02%
Market Cap16.89M Forward P/E- EPS next Y-0.29 Insider Trans0.00% Shs Float14.15M Perf Month107.16%
Income-17.80M PEG- EPS next Q-0.10 Inst Own35.40% Short Float1.49% Perf Quarter68.04%
Sales- P/S- EPS this Y13.10% Inst Trans11.53% Short Ratio0.06 Perf Half Y217.73%
Book/sh0.55 P/B1.62 EPS next Y63.30% ROA-141.40% Target Price1.32 Perf Year17.18%
Cash/sh0.46 P/C1.92 EPS next 5Y- ROE-162.10% 52W Range0.25 - 1.45 Perf YTD53.55%
Dividend- P/FCF- EPS past 5Y32.10% ROI- 52W High-38.58% Beta2.52
Dividend %- Quick Ratio8.90 Sales past 5Y- Gross Margin- 52W Low256.24% ATR0.11
Employees7 Current Ratio8.90 Sales Q/Q- Oper. Margin- RSI (14)68.92 Volatility21.48% 11.39%
OptionableNo Debt/Eq0.00 EPS Q/Q56.30% Profit Margin- Rel Volume0.47 Prev Close0.87
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume3.66M Price0.89
Recom2.30 SMA2079.96% SMA5083.93% SMA20061.74% Volume1,715,770 Change2.37%
Jun-02-20Downgrade Ladenburg Thalmann Buy → Neutral
Feb-13-18Initiated Ascendiant Capital Markets Buy $7
Sep-15-20 04:56PM  
Sep-14-20 04:31PM  
Jun-01-20 09:50AM  
May-30-20 06:39PM  
May-15-20 06:30AM  
May-12-20 10:38AM  
Apr-07-20 03:17PM  
Mar-17-20 07:30AM  
Mar-02-20 06:30AM  
Jan-13-20 06:30AM  
Jan-10-20 05:19PM  
Dec-22-19 01:51PM  
Nov-29-19 08:30AM  
Nov-13-19 07:30AM  
Oct-29-19 07:30AM  
Oct-09-19 08:07AM  
Aug-29-19 08:30AM  
Aug-13-19 04:05PM  
Jul-22-19 06:00AM  
Jul-11-19 10:28AM  
Jun-10-19 08:30AM  
May-17-19 04:55PM  
May-14-19 04:05PM  
May-02-19 04:01PM  
Apr-30-19 09:13AM  
Apr-22-19 08:00AM  
Mar-28-19 08:00AM  
Feb-20-19 08:00AM  
Feb-19-19 08:00AM  
Feb-15-19 11:14PM  
Feb-11-19 08:00AM  
Jan-30-19 08:00AM  
Jan-08-19 08:00AM  
Dec-25-18 11:21AM  
Dec-04-18 08:00AM  
Nov-27-18 11:51AM  
Nov-15-18 08:00AM  
Nov-13-18 08:00AM  
Sep-26-18 08:30AM  
Sep-07-18 09:25AM  
Sep-04-18 04:05PM  
Aug-07-18 08:30AM  
Jun-19-18 07:30AM  
May-11-18 09:15AM  
Apr-02-18 09:00AM  
Jan-05-18 07:20PM  
Nov-21-17 03:00PM  
Nov-08-17 04:52PM  
Nov-06-17 04:01PM  
Oct-05-17 09:26AM  
Aug-09-17 06:08PM  
Jul-10-17 06:30AM  
Jun-12-17 08:00AM  
Novus Therapeutics, Inc., a specialty pharmaceutical company, focuses on developing products for patients with disorders of ear, nose, and throat. Its lead product is OP0201, a surfactant-based nasal aerosol drug-device combination product for patients at risk for, or with, otitis media (OM) (middle ear inflammation with or without infection). The company also has a foam-based drug delivery technology OP0101 and OP0102 that could be used to deliver drugs into the ear, nose, and sinus cavities. Novus Therapeutics, Inc. is headquartered in Irvine, California.